Giant Biogene Holding Co., Ltd. (2367.HK)
HKD 76.95
(-1.28%)
HKD 76.95
(-1.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.77 Billion CNY | 44.06% |
| 2022 | 1.2 Billion CNY | 29.35% |
| 2021 | 938.77 Million CNY | 39.26% |
| 2020 | 674.1 Million CNY | -4.59% |
| 2019 | 706.52 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | 456.38 Million CNY | 24.94% |
| 2023 Q2 | 365.27 Million CNY | 0.0% |
| 2023 Q1 | 365.27 Million CNY | 14.08% |
| 2023 FY | - CNY | 44.06% |
| 2023 Q4 | 456.38 Million CNY | 0.0% |
| 2022 Q3 | 320.18 Million CNY | 23.56% |
| 2022 FY | - CNY | 29.35% |
| 2022 Q4 | 320.18 Million CNY | 0.0% |
| 2022 Q2 | 259.14 Million CNY | 0.0% |
| 2022 Q1 | 259.14 Million CNY | 0.0% |
| 2021 FY | - CNY | 39.26% |
| 2020 FY | - CNY | -4.59% |
| 2019 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -7666.131% |
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | -460.001% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -87597.191% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 9138.789% |
| Huasheng International Holding Limited | 19.67 Million HKD | -8942.464% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | -2792.119% |
| Evergreen Products Group Limited | 140.78 Million HKD | -1163.923% |
| EC Healthcare | 737.83 Million HKD | -141.163% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | -739.986% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | -171.091% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 24148.875% |
| Takbo Group Holdings Limited | 25.8 Million HKD | -6795.737% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | -1054.038% |